| Gia Ann Deangelis, MD | |
|
1215 Lee St Fl 1, Charlottesville, VA 22908-0816 | |
| (434) 924-2781 | |
| (434) 982-1618 |
| Full Name | Gia Ann Deangelis |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 39 Years |
| Location | 1215 Lee St Fl 1, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023167905 | NPI | - | NPPES |
| 007266481 | Medicaid | VA | |
| 300036020 | Other | VA | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085B0100X | Radiology - Body Imaging | 0101047159 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Virginia Medical Center | Charlottesville, VA | Hospital |
| Augusta Health | Fishersville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Virginia Imaging Llc | 2567479405 | 71 |
| University Of Virginia Physicians Group | 4880590728 | 1397 |
News Archive
PolyMedix, Inc., an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has received patent protection for certain exclusively licensed intellectual property by the issuance to the University of Pennsylvania of U.S. patent number 7,590,517, "Methods, Systems, and Computer Program Products for Computational Design of Amphiphilic Polymers."
Using powerful genetic sequencing technology, a team of investigators, led by researchers at the Icahn School of Medicine at Mount Sinai, scanned the genome of hundreds of individuals, and discovered those diagnosed with autism spectrum disorder (ASD) were more likely to have gene deletions than were people without the disorder.
After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.
No larger than a pack of chewing gum, the prototype developed by EPFL's Integrated Systems Laboratory is deceptively simple in appearance. But this little black case with two thin tubes sticking out contains some real miniaturized high-tech wonders.
Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for four students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation's premier research competition.
› Verified 2 days ago
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
PolyMedix, Inc., an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has received patent protection for certain exclusively licensed intellectual property by the issuance to the University of Pennsylvania of U.S. patent number 7,590,517, "Methods, Systems, and Computer Program Products for Computational Design of Amphiphilic Polymers."
Using powerful genetic sequencing technology, a team of investigators, led by researchers at the Icahn School of Medicine at Mount Sinai, scanned the genome of hundreds of individuals, and discovered those diagnosed with autism spectrum disorder (ASD) were more likely to have gene deletions than were people without the disorder.
After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.
No larger than a pack of chewing gum, the prototype developed by EPFL's Integrated Systems Laboratory is deceptively simple in appearance. But this little black case with two thin tubes sticking out contains some real miniaturized high-tech wonders.
Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for four students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation's premier research competition.
› Verified 2 days ago
| Entity Name | University Of Virginia Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720233596 PECOS PAC ID: 2567479405 Enrollment ID: O20090421000339 |
News Archive
PolyMedix, Inc., an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has received patent protection for certain exclusively licensed intellectual property by the issuance to the University of Pennsylvania of U.S. patent number 7,590,517, "Methods, Systems, and Computer Program Products for Computational Design of Amphiphilic Polymers."
Using powerful genetic sequencing technology, a team of investigators, led by researchers at the Icahn School of Medicine at Mount Sinai, scanned the genome of hundreds of individuals, and discovered those diagnosed with autism spectrum disorder (ASD) were more likely to have gene deletions than were people without the disorder.
After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.
No larger than a pack of chewing gum, the prototype developed by EPFL's Integrated Systems Laboratory is deceptively simple in appearance. But this little black case with two thin tubes sticking out contains some real miniaturized high-tech wonders.
Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for four students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation's premier research competition.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gia Ann Deangelis, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Gia Ann Deangelis, MD 1215 Lee St Fl 1, Charlottesville, VA 22908-0816 Ph: (434) 924-2781 |
News Archive
PolyMedix, Inc., an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has received patent protection for certain exclusively licensed intellectual property by the issuance to the University of Pennsylvania of U.S. patent number 7,590,517, "Methods, Systems, and Computer Program Products for Computational Design of Amphiphilic Polymers."
Using powerful genetic sequencing technology, a team of investigators, led by researchers at the Icahn School of Medicine at Mount Sinai, scanned the genome of hundreds of individuals, and discovered those diagnosed with autism spectrum disorder (ASD) were more likely to have gene deletions than were people without the disorder.
After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.
No larger than a pack of chewing gum, the prototype developed by EPFL's Integrated Systems Laboratory is deceptively simple in appearance. But this little black case with two thin tubes sticking out contains some real miniaturized high-tech wonders.
Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for four students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation's premier research competition.
› Verified 2 days ago
Dr. Norman A. Brenbridge, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 500 Martha Jefferson Dr, Charlottesville Radiology, Charlottesville, VA 22911 Phone: 434-244-4580 Fax: 434-244-4579 | |
Dr. Akhil Khetarpal, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Box 800719, Charlottesville, VA 22908 Phone: 434-924-2150 | |
Thomas J. Druzgal, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Lee St Fl 1, Charlottesville, VA 22908 Phone: 434-243-6888 Fax: 434-982-0943 | |
Rachita Khot, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 545 Ray C. Hunt Drive, Charlottesville, VA 22903 Phone: 434-982-0415 Fax: 434-243-6999 | |
Michael T. Perry, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-9400 Fax: 434-982-1618 | |
Dr. Colin P Derdeyn, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1215 Lee St, Charlottesville, VA 22908 Phone: 434-924-9400 |